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http://dx.doi.org/10.1016/j.ajpath.2012.07.035CorrectionsIn the article entitled, “Elevated Expression of Fn14 in
Non-Small Cell Lung Cancer Correlates with Activated
EGFR and Promotes Tumor Cell Migration and Invasion”
(Volume 181, pages 111–120 of the July 2012 issue of
The American Journal of Pathology), the author footnotes
contained errors. The support footnote and author con-
tribution footnote should have read as follows:
This work was supported in part by NIH grants R01
NS055126 (J.A.W.), R01 CA130940 (N.L.T.), R01
CA103956 (J.C.L.); by the Translational Genomics Re-
search Institute Foundation and Scottsdale Healthcare
Foundation (G.J.W.), St. Joseph’s Foundation (Phoenix,
AZ) for the Heart and Lung Institute Research Initiative
(L.J.I. and R.M.B.), and T32 HL007698 (University of
Maryland School of Medicine to E.C.).
N.L.T. and J.A.W. contributed equally as senior au-
thors on this work.
In the article entitled, “MicroRNA 15a, Inversely Corre-
lated to PKC, Is a Potential Marker to Differentiate be-
tween Benign and Malignant Renal Tumors in Biopsy and
Urine Samples” (Volume 180, pages 1787–1797 of the
May 2012 issue), the ninth author’s name was listed in-
correctly. The correct name is Udo Engelmann.In the article entitled “Activated B Cells in the Granulomas
of Nonhuman Primates Infected with Mycobacterium tu-
berculosis” (Volume 181, pages 508–514 of the August
2012 issue), the authors inadvertently omitted a funding
source. J.L.F. was also supported by NIH grant R01-
AI094745.
In the article entitled, “New Human Antibody Fragments
Homing to Atherosclerotic Endothelial and Subendothe-
lial Tissues: An in Vivo Phage Display Targeting Human
Antibodies Homing to Atherosclerotic Tissues” (Volume
180, pages 2576–2589 of the June 2012 issue), the title
was incorrect. The correct title is “In Vivo Phage Display to
Identify New Human Antibody Fragments Homing to Ath-
erosclerotic Endothelial and Subendothelial Tissues.”
In the article entitled “The Synaptic Accumulation of Hyper-
phosphorylated Tau Oligomers in Alzheimer Disease Is As-
sociated With Dysfunction of the Ubiquitin-Proteasome Sys-
tem” (Volume 181, pages 1426-1435 of the October 2012
issue), Figure 4B, page 1430, contained an error. The au-
thors inadvertently duplicated the bottom right images of
Figure 4A, illustrating control synapses, in the right half of
panel B, labeled as AD synapses. The correction of the
mistake does not alter the conclusions of the article. The
corrected Figure 4 (with legend) appears on page 1890.1889
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AJP November 2012, Vol. 181, No. 5Figure 4. A: Control brain synaptoneurosomes
fixed on glass slides were immunostained
against presynaptic marker vGlut1, postsynaptic
marker MAP2, and total tau (DA9 antibody).
Magnifications of boxed areas represent tau im-
munoreactivity at individual synapses. Top,
postsynaptic; bottom, pre- and postsynaptic. B:
Tau proteins are also detected at presynaptic
and postsynaptic terminals from brains affected
by AD. C: Quantification of the percentage of
synaptic terminals positive for tau in control
(4 cases, 400 presynapses, 276 postsynapses)
and AD temporal cortices (4 cases, 400 presyn-
apses, 287 postsynapses). No significant differ-
ence was found by two-way analysis of variance.
Error bars represent SEM. D: Co-localization of
PSD95 and MAP2 at postsynaptic sites. Scale
bars  1 m (A–D).
